Kyowa Kirin has 5 research facilities focused on discovery and early research efforts worldwide. Across these facilities, we leverage 4 therapeutic platforms to discover drug candidates and develop new treatments for nephrology, oncology, immunology and allergy and the central nervous system (CNS).

Research in North America draws on our strength as a global team to bring new medicines to patients around the world. We focus predominantly on the discovery of next-generation therapeutic antibodies and new small-molecule drugs, with particular expertise in immunology and allergy.